TMO (Thermo Fisher Scientific) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TMO Thermo Fisher Scientific Inc TMO
85 GF Score
Price $651.45
GF Value $599.37
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Thermo Fisher Scientific  (NYSE:TMO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Thermo Fisher Scientific Cyclically Adjusted PB Ratio Related Terms


Thermo Fisher Scientific Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Cyclically Adjusted PB Ratio Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.26 6.68 5.82 5.20 5.29

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.68 5.52 4.52 4.49

TMO vs DHR, NTRA, IDXX: Cyclically Adjusted PB Ratio Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Cyclically Adjusted PB Ratio falls into.


TMO
85GF Score
Thermo Fisher Scientific Inc TMO
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Thermo Fisher Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Thermo Fisher Scientific's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=142.819/333.9520*333.9520
=142.819

Current CPI (Jun. 2026) = 333.9520.

Thermo Fisher Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201609 54.828 241.428 75.840
201612 54.745 241.432 75.724
201703 55.711 243.801 76.311
201706 57.397 244.955 78.250
201709 61.601 246.819 83.348
201712 63.324 246.524 85.781
201803 64.930 249.554 86.889
201806 65.654 251.989 87.009
201809 66.795 252.439 88.363
201812 68.601 251.233 91.188
201903 69.236 254.202 90.957
201906 71.737 256.143 93.529
201909 73.206 256.759 95.215
201912 74.422 256.974 96.716
202003 72.310 258.115 93.555
202006 75.520 257.797 97.829
202009 80.296 260.280 103.024
202012 87.017 260.474 111.564
202103 89.200 264.877 112.462
202106 93.676 271.696 115.141
202109 98.237 274.310 119.596
202112 103.888 278.802 124.438
202203 105.070 287.504 122.045
202206 108.403 296.311 122.174
202209 111.493 296.808 125.446
202212 113.052 296.797 127.205
202303 110.009 301.836 121.714
202306 113.784 305.109 124.540
202309 117.669 307.789 127.671
202312 121.149 306.746 131.894
202403 119.521 312.332 127.794
202406 124.439 314.175 132.272
202409 128.363 315.301 135.956
202412 130.447 315.605 138.030
202503 131.088 319.799 136.889
202506 134.008 322.561 138.740
202509 136.154 324.800 139.990
202512 142.299 324.054 146.645
202603 140.094 330.213 141.680
202606 142.819 333.952 142.819

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Thermo Fisher Scientific (TMO) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be overvalued. The current stock price of $651.45 is trading 8.7% above its estimated GF Value™ of $599.37. GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.

Key valuation signals for TMO:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $599.37 vs. price of $651.45 (8.7% above fair value)
  • GF Score™: 85/100 with 10 warning signs

No single metric tells the full story. See the TMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
85GF Score

Get the complete analysis for TMO

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$651.45
Price
$599.37
GF Value